NVCRHealthcareSmall-Cap
NovoCure Ltd Insider Trading Activity
Every SEC Form 4 insider transaction reported for NovoCure Ltd (NVCR), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are NVCR insiders buying or selling?
NovoCure Ltd insiders reported 3 open-market buys ($1.7M) and 326 sells ($505.5M) across 329 Form 4 filings — a net selling position of $503.7M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jun 5, 2026)
Total Form 4 filings
329
SEC EDGAR
Insider filers
26
Insider buys (3)
$1.7M
Insider sells (326)
$505.5M
Insider sentiment
Net sellingNet insider flow of $503.7M in net selling.
Recent NVCR insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Frank X Leonard | Chief Executive Officer | Sale | 34.3K | $17.93 | $614.6K |
| Jun 3, 2026 | Gabriel Leung | Director | Sale | 2.9K | $15.77 | $46.4K |
| Jun 3, 2026 | Kristin Stafford | Director | Sale | 2.9K | $15.77 | $46.4K |
| Jun 3, 2026 | Allyson J Ocean | Director | Sale | 2.9K | $15.77 | $46.4K |
| Jun 3, 2026 | Timothy J Scannell | Director | Sale | 2.9K | $15.77 | $46.4K |
| Jun 3, 2026 | Jeryl L Hilleman | Director | Sale | 2.9K | $15.77 | $46.4K |
| Jun 3, 2026 | Anthony W Vernon | Director | Sale | 2.9K | $15.77 | $46.4K |
| Jun 3, 2026 | Hung David | Director | Sale | 2.9K | $15.77 | $46.4K |
| Mar 5, 2026 | Nicolas Leupin | Former Chief Medical Officer | Sale | 1.1K | $13.31 | $14.6K |
| Mar 3, 2026 | Uri Weinberg | Chf Medical and Innovation Ofr | Sale | 10.7K | $13.68 | $146.9K |
| Mar 3, 2026 | Michal Nath Puri | Chief Human Resources Officer | Sale | 1.4K | $13.66 | $19.7K |
| Mar 3, 2026 | Frank X Leonard | Chief Executive Officer | Sale | 17.0K | $13.59 | $230.6K |
| Sep 8, 2025 | Ashley Cordova | Chief Executive Officer | Purchase | 81.5K | $12.22 | $996.9K |
| Jul 30, 2025 | Christoph Brackmann | Chief Financial Officer | Purchase | 20.0K | $11.59 | $231.8K |
| Jun 4, 2025 | Kristin Stafford | Director | Sale | 999 | $17.28 | $17.3K |
| Jun 4, 2025 | Gabriel Leung | Director | Sale | 999 | $17.31 | $17.3K |
| Jun 4, 2025 | Martin J. Madden | Director | Sale | 999 | $17.19 | $17.2K |
| Jun 4, 2025 | Timothy J Scannell | Director | Sale | 999 | $17.32 | $17.3K |
| Jun 4, 2025 | Jeryl L Hilleman | Director | Sale | 999 | $17.26 | $17.2K |
| Jun 4, 2025 | Allyson J Ocean | Director | Sale | 999 | $17.29 | $17.3K |
| Jun 4, 2025 | Anthony W Vernon | Director | Sale | 999 | $17.35 | $17.3K |
| Jun 4, 2025 | Hung David | Director | Sale | 999 | $17.30 | $17.3K |
| Jun 4, 2025 | Frank X Leonard | EVP, Pres., Novocure Oncology | Sale | 30.2K | $17.50 | $528.4K |
| May 5, 2025 | Mukund Paravasthu | Chief Operating Officer | Sale | 592 | $17.91 | $10.6K |
| Mar 4, 2025 | Uri Weinberg | Chief Innovation Officer | Sale | 268 | $18.92 | $5.1K |
Showing the 25 most recent of 329 Form 4 filings for NovoCure Ltd.
Most active NVCR insiders
- Pritesh Shah45 filings
- Wilhelmus CM Groenhuysen43 filings
- Gabriel Leung35 filings
- Frank X Leonard30 filings
- Asaf Danziger24 filings
Ask anything about NVCR insider activity
Use Trabud's AI agent to query NovoCure Ltd's Form 4 history in plain English — "Show me NVCR CEO purchases this year" or compare it against any other ticker.
Open the AI agentNVCR insider trading FAQ
Are NovoCure Ltd insiders buying or selling?
Across 329 SEC Form 4 filings, NovoCure Ltd (NVCR) insiders reported 3 open-market purchases totaling $1.7M and 326 sales totaling $505.5M. That is a net selling position of $503.7M.
How many insiders trade NVCR stock?
26 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for NovoCure Ltd. The most recent filing was accepted on Jun 5, 2026.
Where does Trabud get NVCR insider trading data?
All NVCR insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.